SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) — Shareholder Rights Law Firm Johnson Fistel, LLP (www.JohnsonFistula.com) is investigating whether Ally Financial Inc. (“Ally” or the “company“) ALLIES, one of its officers or others has violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they can be recovered under federal securities laws.

What if I bought Ally common stock? If you bought Ally common stock and suffered significant losses on your investment, join our investigation now:

There are no costs or obligations for you.

What does Johnson examine fistula? On October 19, 2022, Ally released its third quarter financial results. Net income fell to $272 million, or 88 cents a share, from $712 million, or $1.89 a share, in the year-ago quarter. Adjusted earnings fell to $1.12 per share from $2.16 per share in the year-ago quarter. On October 18, 2022, the company announced that Jennifer A. LaClair had left her position as chief financial officer.

What if I have relevant non-public information? Those with nonpublic information about the company should consider cooperating with our investigation or participating in the SEC’s whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to 30% for each successful recovery by the SEC. For more information, contact Jim Baker at (619) 814-4471 or jimb@johnsonfistula.com.

Contact:
Johnson Fistula, LLP
Jim Baker, Senior Securities Analyst
Phone: (619) 814-4471
E-mail: jimb@johnsonfistula.com